Snowball logo
logo
GALD

Galderma Group N

GALD SW
Fr125.60+Fr0.40  (0.32%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
Start

Frequently asked questions

What sector does Galderma Group N (GALD) operate in?

Galderma Group N belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Galderma Group N (GALD) current stock price?

As of the latest data, Galderma Group N stock price is CHF 125.60, with a previous close of CHF 125.20. Galderma Group N gained CHF 0.40 in the last trading session, representing a 0.32% increase.

What is Galderma Group N (GALD) current market capitalization?

Galderma Group N market cap is approximately 29.82 billion.

What is Galderma Group N (GALD) Earnings Per Share (EPS)?

The trailing EPS is CHF 0.79, and the forward EPS is CHF 3.85.

What is Galderma Group N (GALD) Price-to-Earnings (P/E) ratio?

Galderma Group N current P/E ratio is 158.99, with a forward P/E of 32.59.

What is Galderma Group N (GALD) EBITDA?

Galderma Group N EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 494.36 million.

Does Galderma Group N (GALD) pay dividends?

Yes. Galderma Group N pays annual dividends with an annualized yield of 0.12% and an estimated annual payout of CHF 0.15 per share.

When is the next ex-dividend date for Galderma Group N (GALD)?

The next ex-dividend date is scheduled for April 25, 2026.

When is Galderma Group N (GALD) next earnings report?

Galderma Group N is expected to release its next earnings report on June 30, 2025.

What is Galderma Group N (GALD) beta (volatility) score?

Galderma Group N has a beta of 0.170, indicating lower volatility than the overall market.